Adult growth hormone deficiency metabolic alterations and evaluation of different risk groups

Medicina

Volumn 64, Issue 1, 2004, Pages 13-19

  Fideleff, Hugo L ^a,e   Chervin, Alberto ^b,d   Giaccio, Anna ^a   Sobrado, Patricia ^a   Barmat, Ricardo ^a   Boquete, Hugo ^a   Bruera, Darío ^c   Claus, Haraldo ^e   Levalle, Oscar ^f   Miras, Mirta ^g   Sinay, Isaac ^h   Stalldecker, Gracia ⁱ  

^a Hospital General De Agudos Teodoro Alvarez   (Argentina)

^b Hospital Oftalmologico Santa Lucia   (Argentina)

^c Hospital Clínicas de Córdoba   (Argentina)

^d Hosp S Lucia   (Argentina)

^e HOSPITAL ALEMÁN   (Argentina)

^f HOSPITAL DURAND   (Argentina)

^g Hospital of Nino Jesus   (Argentina)

^h HOSPITAL FRANCÉS   (Argentina)

ⁱ Hospital Pirovano   (Argentina)

Author keywords

Adult growth hormone deficiency; Growth hormone; Metabolic alterations

Indexed keywords

ALKALINE PHOSPHATASE; CHOLESTEROL; DEOXYPYRIDINOLINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OSTEOCALCIN; PROCOLLAGEN; PYRIDINOLINE; SOMATOMEDIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY MASS; BONE MINERAL; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DECELERATION; DENSITOMETRY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERGOMETRY; FEMALE; GENDER; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEART INDEX; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OSTEOPOROSIS; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTHROPOMETRY; ARGENTINA; BODY CONSTITUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DENSITOMETRY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION;

EID: 12144291689     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jorgensen JOL, Thuesen L, Ingemannhansen T et al. Beneficial effects of growth hormone treatment in GH deficient adults. Lancet 1989; 1: 1221-5.
2. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-803.
3. De Boer H, Blok G-J, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev1995; 16: 63-86.
4. Rosén T, Edén S, Larsson G, Wilhelmsen L, Bengtsson B-Å. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993; 129: 195-200.
5. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-92.
6. Rosén T, Bengtsson B-Å. Premature mortality due to car-diovascular diseases in hypopituitary. Lancet 1990; 336: 285-8.
7. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992; 37: 387-97.
8. Attanasio AF, Lamberts SWJ, Matranga AMC, et al. Adult growth hormone (GH)-deficient patients demon- strate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 1997; 82: 82-8.
9. Shalet SM, Toogood A, Rahim A, Brennan B. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19(2): 203-23.
10. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998; 83: 379-81.
11. Fideleff HL, Frigeri AE, Sobrado PG, Llano MN, Ruibal GF, Boquete HR. Reproducibility and Variability of the Arginine test in Normal Adults: Comparison between sexes. Medicina (Buenos Aires)1999; 59: 249-53.
12. Siegel S. Non parametric statistics for the behavioral sciences, 5th ed. New York: Mc Graw, 1990, p 143-55.
13. Siegel S. Non parametric statistics for the behavioral sciences, 5th ed. New York: Mc Graw, 1990, p 233-45.
14. Johannsson G, Bjarnason R, Bramnert M et al. The individual responsiveness to growth hormone (GH) treatment in GH- deficient adults is dependent on the level of GH- binding protein, body mass index, age and gender. J Clin Endocrinol Metab 1996; 81: 1575-81.
15. Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults. Eur J Endocrinol 1999; 141: 601-8.
16. Thorner MO, Bengtsson B-Å, Ho KY et al. The diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 1995; 80: 3097-8.
17. Janssen YJ, Frolich M, Roelfsema F. A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metabol 1997; 82 (1): 129-35.
18. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R, Johnston D. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol 1994; 130: 451-8.
19. Attanasio AF, Howell S, Bates PC et al. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH- deficient (GHD) patients after childhood GH treatment: A comparison with adult onset GHD patients. J Clin Endocrinol Metab 2002; 87 (7): 3368-72.
20. Luger A. Baseline characteristics of patients enrolled in KIMS. In: Bengt-Åke Bengtsson B-Å, Monson JP (eds). GH Replacement in Adults. The first 5 years of KIMS. Oxford PharmaGenesis™ Ltd., Oxford, UK, 2000, p 105-11.
21. Koranyi J, Svensson J, Götherström G, Sunnerhagen KS, Bengtsson B-Å, Johannsson G. Baseline Characteristics and the Effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: A comparative, prospective study. J Clin Endocrinol Metab 2001, 86: 4693-9.
22. Bates AS, Vant Hoff W, Jones PJ, Clayton RN. The Effect of Hypopituitarism on Life Expectancy. J Clin Endocrinol Metab 1996; 81: 1169-72.
23. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: A 13 year follow-up of participants in the study of men born in 1913. Br Med J 1984; 288: 1401-4.
24. Wing RR, Jefferey RW, Burton LR, Kuller LH, Thorson C, Folsom AR. Change in waist-hip ratio with weight loss and its association with change in cardiovascular risk factors. Am J Clin Nutr 1992; 55: 1086-92.
25. Rosén T, Johannsson G, Johansson J-O, Bengtsson B-Å. Consequences of growth deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Horm Res 1995; 43: 93-9.
26. Reaven GH. Role of insulin in human disease. Diabetes 1988; 37: 1595-607.
27. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Publ Health 1988; 78: 676-9.
28. Christ ER et al. Growth hormone replacement in adults with growth hormone deficiency improves vascular endothelial function, Clin Endocrinol 1999; 51: 21-5.
29. McCallum RW, Petrie JR, Dominiczak AF, Connell JM. Growth Hormone Deficiency and Vascular Risk. Clin Endocrinol 2002; 57: 11-24.
30. Bengtsson B-Å, Christiansen JS, Cuneo RC, Saccà L. Cardiovascular Effects of GH. J Endocrinol 1997; 152: 1-3.
31. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth Hormone and the Heart. J Clin Endocrinol Metab 2001; 54: 137-54.
32. Longobardi S, Cuocolo A, Merola B et al. Left ventricular function in young adults with childhood ad adulthood onset growth hormone deficiency. Clin Endocrinol 1998; 48: 137-43.
33. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I. Cardiac Performance and Mass in Adults with Hypopituitarism: Effects of One Year of Growth Hormone Treatment. J Clin Endocrinol Metab1995; 80: 659-66.
34. Fazio S, Palmieri EA, Biondi B, Cittadini A, Saccà L. The role of the GH-IGF-I axis in the regulation of myocardial growth: From experimental models to human evidence. Eur J Endocrinol 2000; 142: 211-6.
35. Colao A, Di Somma C, Pivonello R, et al. Bone Loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999; 84: 1919-24.
36. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 669-74.
37. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-23.
38. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997; 137: 240-5.
39. Balducci R, Toscano U, Pasquino AM et al. Bone Turnover and Bone Mineral Density in Young Adult Patients with Panhypopituitarism before and after Long-term Growth Hormone Therapy. Eur J Endocrinol 1995; 132: 42-6.
40. Simpson H, Savina R, Sörksen R et al. Growth Hormone Replacement Therapy for adults: Into the New Millennium. Growth Horm IGF Res 2002; 12: 1-33.
41. Ferretti JL, Schiessl H, Frost HM. On new opportunities for absorptiometry. J Clin Densitometry 1998; 1: 41-53.